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Abstract
Multiple sclerosis (MS) is the most common chronic inflammatory disorder of the central nervous system (CNS) in
young adults. The disease causes a wide range of symptoms depending on the localization and characteristics of
the CNS pathology. In addition to drug-based immunomodulatory treatment, both drug-based and non-drug
approaches are established as complementary strategies to alleviate existing symptoms and to prevent secondary
diseases. In particular, physical therapy like exercise and physiotherapy can be customized to the individual
patient’s needs and has the potential to improve the individual outcome. However, high quality systematic data on
physical therapy in MS are rare. This article summarizes the current knowledge on the influence of physical activity
and exercise on disease-related symptoms and physical restrictions in MS patients. Other treatment strategies such
as drug treatments or cognitive training were deliberately excluded for the purposes of this article.
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Background of MS
MS is a chronic inflammatory disease of the CNS, which
causes multifocal demyelination along with astrocytic
gliosis and variable axon loss in the brain and spine. MS
is one of the most common causes of non-traumatic
disability in young adults and approximately 1-2.5 mil-
lion people around the world are estimated to be
affected, depending on the publication [1,2]. Women are
more likely to develop the disease than men (female:
male ratio approximately 2-3:1). MS usually manifests
between the age of 20 to 40 years, rarely much earlier
during childhood, or in old age. The disease course is
usually relapsing-remitting with progression into a sec-
ondary progressive form after a varying period of time
or primary progressive right from the start. The precise
etiology of MS still remains unclear. A combination of
environmental and genetic factors which lead to autoim-
mune reactions against CNS-structures which in turn
result in CNS tissue damage and neurological impair-
ment is assumed to be the most likely pathomechanism
[2,3].
Depending on the localization and characteristics of
the morphological changes in both white and gray
brain matter, different symptoms and signs may occur,
such as visual impairment, dysarthria and dysphagia,
spasticity, paresis, coordination and balance impair-
ment, ataxia, pain, sensory impairment, bladder, bowel
and sexual dysfunction [3-7]. Fatigue, emotional and
cognitive changes are also frequently present in MS
[8-13]. These symptoms, often in combination with a
lack of confidence in one’s own capabilities and abil-
ities to manage the symptoms, lead to impaired func-
tional capacity and subsequently reduced physical and
sporting activity as well as reduced quality of life
[14-18]. As in other conditions with reduced mobility,
in MS the lack of physical activity can lead to second-
ary sequelae such as obesity, osteoporosis, and/or car-
diovascular damage which in turn pose a serious threat
to patients as they increase the risk of further compli-
cations like thrombosis, pulmonary embolisms, upper
respiratory or urinary tract infections, or prominent
decubital ulcers [15,16,19].
According to the autoimmune etiopathology, immu-
nomodulatory drugs such as interferon-b or glatiramer
acetate are the treatment of choice. If these drugs are
not sufficiently effective, escalation therapy with immu-
nosuppressive substances (mitoxantrone), monoclonal
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antibodies (natalizu-mab) or the recently approved
sphingosinphosphat receptor modulator fingolimod may
be required (Figure 1) [20-22].
Definitions
For the purpose of this article the terms movement,
physical activity, exercise, physical function, physical
therapy, physiotherapy and sport will be used according
to the following definitions (Tables 1 and 2): In terms of
the motor system, the term “movement” includes an
actively or passively induced change in the position of
the body. Regular exercise and physical activity are deci-
sive factors in a person’s quality of life by sustainably
improving health and wellbeing and preventing diseases
at all stages of life. As opposed to sport, in which the
focus is on physical achievement, competition and fun,
physical activity encompasses any type of physical move-
ments, which consume energy, regardless of the under-
lying motivation. The term “health-enhancing physical
activity” includes both leisure-time activities (e.g. sport)
and everyday activities (e.g. climbing stairs). The inten-
sity of the activity is categorized according to the meta-
bolic equivalent (MET; 1 MET corresponds to the
oxygen uptake of an adult whilst sitting = 3.5 ml (men)
and 3.2 ml (women) O2/kg/min) into light (<3 MET),
moderate (3-6 MET) and vigorous (>6 MET). In con-
trast to general physical activity, exercise encompasses
the planned performance of systematically repeated
movements to accomplish skills, maintain and
strengthen physical condition, and improve perfor-
mance. Athletics, more specifically, aims to improve
general flexibility and includes endurance training to
maintain performance over longer periods of time at a
high level and strength training to increase muscle
strength. The terms endurance and aerobic training as
well as resistance and strength training are often used
synonymously. Physical function encompasses “a series
of increasingly integrated steps, with the highest level
consisting of the most advanced activities of daily life
(ADL), the fulfillment of societal roles and the pursuit of
recreational activities“ [16]. The term “physiotherapy”
includes manual skills, that are appropriately supple-
mented by remedies like water, heat, light, or electricity
and aims to restore functionality and conscious percep-
tion of the human body. Active and/or passive training
programs are part of physiotherapeutic methods. On the
contrary “physical therapy” is rather used as an
umbrella-term, comprising different kinds of physical
Figure 1 Drug-based and non-drug-based symptomatic treatment approaches for MS complement each other in almost every stage
of disease. Drug-based strategies encompass basic treatments (interferon-b or glatriameracetete) and – if these drugs are not sufficiently
effective – escalation therapy with immunosuppressive substances (mitoxantrone), monoclonal antibodies (natalizumab) or sphingosinphosphat
receptor modulator fingolimod. Non-drug strategies like physical therapy (physiotherapy, ergotherapy, logopedics, rehabilitaton) and
occupational therapy (sociotherapy and psychotherapy) are used complementarily in all stages of the disease
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activity like exercise, (functional) training, physiotherapy,
and rehabilitation.
Symptomatic treatment of MS – aiming at a
personalized modification of symptoms and
outcome
Drug-based and non-drug-based symptomatic treatment
approaches for MS complement each other. Drug-based
approaches which are referred to in comprehensive
reviews [21,22] are beyond the scope of this article.
Apart from counseling and nursing care, non-drug stra-
tegies encompass physical therapy like physiotherapy,
logopedics, occupational therapy including living and
mobility aids, sociotherapy and psychotherapy (Figure
1). These measures can be applied multimodally, mean-
ing that several approaches are combined in a patient’s
treatment strategy and should generally complement
drug therapy [4,23,24]. Physical therapies are developed
depending on the individual symptoms and positively
affect several factors at the same time. Importantly,
apart from reducing symptoms, enhancing mobility,
improving quality of life and conferring as much inde-
pendence as possible, for example by functional training
of ADLs, such as washing, eating, drinking, dressing,
and performing household chores, symptomatic thera-
pies may prevent potentially life-threatening secondary
diseases [15,25]. Physical therapies can be applied in
almost every stage of disease – from the first onset of
symptoms to highly impaired patients and palliative
conditions. In contrast to physiotherapy, exercise is not
part of commonly used therapies offered to MS patients;
however it might be a promising and cost-effective tool
to improve various functions in patients with MS.
Exercise in MS patients – effects on clinical
parameters (Table 3)
Impairment of MS patients like spasticity or paresis is pri-
marily a consequence of disease progress (morphological
changes), but it can be aggravated by reduced physical
activity [14,26]. Exercise has been shown to improve var-
ious aspects of the physiological profile of MS patients; in
particular, inactivity-related impairment can be alleviated
by exercise [26]. However, recommendations on exercise
for patients with MS have to face a number of limitations:
Although there is a large number of studies on which
recommendations have been based, many of these studies
have limitations, including small sample sizes, lack of an
appropriate control group, unblinded design, and failure
to distinguish between different courses and stages of the
disease. In fact, only occasionally a randomized controlled
and blinded study design is applied. Training regimes are
often not standardized, and the interventions are hardly
sufficiently described. The comparability of studies is
furthermore limited by variable treatment duration
extending over a short period of weeks up to few months,
different treatment frequency and different treatment
intensity. Long term-effects of the respective interventions
are rarely reported [14,27-31]. Furthermore, effects of
exercise have been studied almost exclusively in MS
patients with slight or moderate impairment (score on the
expanded disability status scale (EDSS) less than 7) [14].
To our knowledge only one recently published study
examined highly impaired MS patients with an EDSS of 5-
8 [32].
In summary, despite the often insufficient methodolo-
gical quality of the studies and the insufficiently
described training regimes [14,29,33] most of these stu-
dies including exercise programs of resistance (e.g. pro-
gressive resistance exercise, walking mechanics),
endurance (e.g. bicycle ergometry, arm or arm-leg ergo-
metry, aquatic exercise, treadmill walking) as well as
combined training provided evidence for a benefit of
exercise in MS patients [14,15,28,29]. These training
programs are referred to in more detail below. All train-
ing programs have been well tolerated by the patients.
Nearly 100% of inpatient participants and 59-96% parti-
cipants of home-based trials completed without occur-
rence of adverse events [34-38].
Endurance training
Moderate endurance training resulted in improved mus-
cle strength of both lower and upper extremities and
Table 2 Types of human movements, sorted according to
intensity
Type of human movements
Movement ® Physical activity ® Physical function ® Exercise ® Sport
Table 1 Definitions of different types of physical movements
Definitions
Movement Active or passive change in the position of the body
Physical activity Any type of physical movement that consumes the subject’s energy
Physical
function
A series of increasing steps, with the highest level consisting of the most advanced activities of daily life, the fulfillment of social
roles and the pursuit of recreational activities
Exercise Planned performance of systematically repeated movements to accomplish skills, maintain and strengthen physical condition, and
improve performance
Sport Exercise with a focus on physical achievement, competition, and fun
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Table 3 Overview of selected studies on exercise in multiple sclerosis
Form of
training
Author Method (Major) Endpoints Sample
size
EDSS Main Results Comments
Aerobic
training
Newman
[27]
Treadmill walking Gait parameters,
Fatigue
16 <7 Improvements in some gait
parameters, fatigue
unchanged
Repeated
measures design
and blinded
assessments
Pilutti [32] Body-weight
supported treadmill
training (BWSTT)
Functional ability,
quality of life,
Fatigue
6 5,5-8 Improvements in some
functional abilities and some
parameters of quality of life,
Fatigue non-significantly
reduced
Patients with
progressive MS of
high disability
Rampello
[42]
Aerobic training
program compared
with neurological
rehabilitation
Walking parameters,
maximal exercise
tolerance, quality of
life, fatigue
19 < 6 Improvements of some
walking parameters after
aerobic training, Fatigue
after aerobic training and
neurological rehabilitation
comparable
Only 11 patients
completed
Schulz [44] Aerobic training Immune-endocrine
parameters,
neurotrophic factors,
quality of life,
coordinative
function
67 <5 Lactate levels lowered,
quality of life increased and
coordinative increased
Van den
Berg [47]
Aerobic treadmill
training
Walking parameters,
fatigue
19 Walk 10 m in
60 s, using aid
if necessary
Improvements of some
walking parameters after
aerobic treadmill training,
fatigue not significantly
reduced
Prospective,
randomized
controlled trial
with blinded
assessments, 16
patients
completed
Mostert
[48]
Aerobic training Aerobic fitness,
fatigue, health
perception, activity
level
26 <6.5 Improvement of health
perception, activity level
Randomized trial
Resistance
Training
Dodd [28] Progressive
resistance
strengthening
Physical,
psychological, social
factors
8 no information Fatigue reduced significantly Semi-structured
interviews
Dalgas [31] Progressive
resistance training
Muscle strength,
functional capacity
38 3-5.5 Muscle strength and
functional capacity increased
Randomized
controlled trial
including follow-
up
Harvey [39] General
physiotherapy
exercises,
strengthening
training
Muscle strength,
functional activities
19 Ambulant with
or without the
use of walking
aids
Muscle strength and
functional activities
improved
White [30] Progressive
resistance training
Lower extremity
strength, ambulatory
function, fatigue,
disability
8 1-5 Lower extremity strength
increased
Taylor [40] Progressive
resistance training
Maximal muscle
force, muscle
endurance,
functional activity,
psychological
function
9 able to walk at
least 200 m
without aid or
rest
Improvements in muscle
strength, muscle endurance,
and functional activity
Pre/post single
group research
design
Gutierrez
[49]
Resistance training Kinematic gait
parameters, isometric
strength, stepping,
fatigue, disability
8 2.5-5.5 Increases in some kinematic
gait parameters, fatigue
decreased
Broekmans
[101]
Resistance training Muscle strength,
functional mobility
36 2-6.5 Improvements in muscle
strength and some
functional parameters
Randomized
controlled trial,
long-term
investigation (20
weeks)
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some functional measures like walking speed, fatigue,
and quality of life [14,15,17,28,29,31,34]. Some authors
reported beneficial effects in chair transfer [14,39], gait,
stair climbing, and timed up and go test (standing up
from a chair, walking 3 m, turning around and seat
again) [14,35,40]. But, as described above, varying and
contradictory results were found. For example, some
authors reported marked improvements in aerobic capa-
city, measured by maximal oxygen uptake (VO2-max),
[14,41,42], whereas others did not observe significant
improvements [14,43,44].
The same applies to fatigue as there is some evidence
for an improvement of fatigue by endurance training
[30,35,45], whereas other studies missed the level of sta-
tistical significance [14,28,35] or did not reveal any dif-
ferences at all [27,46,47].
Contradictory data have been reported on various
items of health related quality of life like vitality [14,48],
social functioning [14,44,48], mood [14,42,44], energy
[14,42], anger [14,41], sexual function [14], bladder and
bowel function [41], and depression [14,41].
One group analyzed the effect of a 6 months outpati-
ent aerobic training program in MS patients with mild
to moderate disability (EDSS 1-6) and observed a trend
for larger benefits in more severely disabled than in
less affected patients, but the study is limited by the
small sample size of 19 patients of which only 11
patients completed the study [42]. Therefore, these
results have to be handled with care and further stu-
dies are required.
Resistance training
Resistance training is known to enhance muscle strength
in healthy people. In MS patients there is also evidence
for improving muscle strength [35,40]. Furthermore,
beneficial effects on walking speed, stepping endurance,
stair climbing, timed up and go test, self-reported dis-
ability, and self-reported fatigue have been described in
MS patients as well as significant improvements in gait
disturbances, measured by Dynamic Gait Index [35,49].
There are different forms of resistance training. One
form, for example, constitutes progressive resistance
exercise (PRE), which according to Taylor et al. com-
prises the following three principles: “1. perform a small
number of repetitions with relatively high loads until
muscle fatigue is reached, 2. allow sufficient rest between
Table 3 Overview of selected studies on exercise in multiple sclerosis (Continued)
Combined
training
Romberg
[34]
Strength, aerobic
training
Walking speed,
lower extremity
strength, upper
extremity endurance,
dexterity, static
balance
95 1-5.5 Walking speed improved 6-month exercise
program,
randomized study,
91 patients
completed
Cakit [35] Cycling progressive
resistance training,
balance exercises
Walking parameters,
balance, fatigue, fear
of falling, depression,
quality of life
45 of ≤ 6.0, ability
to stand
independently
in upright
position for >3
s
Improvements in walking
parameters, fatigue, fear of
falling, depression
Randomized (two
exercise training
and one control
group), only 33
patients
completed
Smith [46] Strengthening,
stretches, fitness
exercises
Function, fatigue,
sensory symptoms
34 0-6 > 40% temporary increased
sensory symptoms (number
or intensity)
Single exercise
session with
follow up, all
measures self-
rated
Surakka
[50]
Aerobic and strength
exercise
Motor fatigue 95 1-5.5 Motor fatigue reduced in
women (not in men)
Randomized
controlled trial
Others Motl [17] Wearing an
accelerometer
Physical activity,
quality of life,
disability, fatigue,
mood, pain, self-
efficacy, social
support
292 no information Improvements in disability,
fatigue, depression, pain,
self-efficacy, social support
No specific
training-protocol,
completed self-
report measures
Rasova [43] Neurophysiologically
based physiotherapy,
aerobic training,
combined therapy
Impairment,
disability, handicap,
quality of life,
fatigue, depression,
respiratory function,
physical fitness
112 0-6.5 Improvements in training
groups with different impact
on parameters, fatigue
reduced
Randomized
(three exercise
training and one
control group),
only 95 patients
completed
Wiles [51] Physiotherapy Mobility, mood 42 4.0-5.5 Improvements in mobility,
subjective wellbeing, and
mood
Randomized
controlled
crossover trial
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exercise for recovery, and 3. increase the load as the abil-
ity to generate muscle force development“ [40].
Cakit et al. examined the effect of PRE by means of
cycling progressive resistance training and lower-limb
strengthening, both combined with balance exercise in a
prospective randomized controlled trial of 45 MS
patients [35]. After 8 weeks, patients in the two training
groups performed better with respect to 10 m walking
test, duration of exercise, and timed up and go test than
patients in the control group who received no interven-
tion. Moreover, the training groups showed evidence for
superior effects on balance, fatigue, depression, and fear
of falling.
Taylor et al. investigated the effect of a 10 week PRE
program on maximal muscle force, muscle endurance,
functional activity, and overall psychological function in
MS patients [40]. The authors reported significant
improvements of arm strength, leg endurance, and fast
walking speed, and a trend towards improvement in the
2-min walk-test and day-to-day life function.
Besides PRE, other training forms like strategies to
promote proper gait mechanics, focusing on weight
bearing, weight shifting, and body positioning, or weigh-
tlifting are used [49]. For example, Pilutti et al. exam-
ined the effect of resistance exercise in six severely
disabled patients (EDSS 5-8) with progressive MS (five
patients with primary progressive, one patient with sec-
ondary progressive disease course) by means of a 12
week course of body-weight supported treadmill training
performed three times weekly for 30 min [32]. The
patients improved in terms of training intensity tread-
mill walking speed and required body weight support as
well as in physical and mental subscales of a quality of
life questionnaire. Fatigue was not reduced.
Combined endurance and resistance training
Only few authors examined the effect of combined resis-
tance and endurance training in MS. Small improve-
ments both in muscle strength and gait velocity have
been described [14,34,50]. Interestingly, in a compara-
tively large study on 95 MS patients, Surakka et al.
observed significant training effects after six months of
combined resistance and endurance training only in
women, but not in men, which might be explained by a
25% higher exercise activity in women [50]. Further-
more, Romberg et al. reported significant improvements
in walking speed and upper extremity endurance follow-
ing six months combined exercise training, whereas
lower extremity strength, VO2-max, static balance, and
manual dexterity did not improve [34].
In 2005, the Cochrane Collaboration published a first
systematical review on the effects of exercise on ADL
and health-related quality of life (HRQoL) and the
effects of physical therapy on various symptoms in MS
patients [33]. Only controlled, randomized clinical stu-
dies on adult MS patients not experiencing an exacerba-
tion at the time were included. Six studies, of which
four have so far only been published as an abstract, ana-
lyzed the effects of physical therapy (rehabilitation, phy-
siotherapy, exercise, functional training, independent
home-based training, aquatic exercise) on several dis-
ease-related variables compared to a control group that
had not received any physical therapy [36,39,41,51-53].
Three other studies compared the results of two differ-
ent physical therapy programs. In summary, muscle
strength, movement (changing and maintaining posture,
walking, moving around, timed transfer, walking
cadence), and exercise tolerance tests (modified graded
exercise test, VO2-max, and physiological cost index) all
showed substantial improvement. Mood parameters
(fear, depression) showed only moderate improvement
and EDSS, fatigue, cognitive parameters and ADL
remained unchanged [18,37,48].
Asano et al. assessed the methodological quality of
selected randomized controlled trials (RCT) of exercise
interventions in MS carried out from 1950 to 2007 [29].
They found evidence for positive effects of exercise on
physical and psychosocial functioning and quality of life,
but highlighted a great need for high quality RCTs in
this field.
Exercise in MS patients – the impact of body temperature
on disability
In 1890 the German ophthalmologist Wilhelm Uhthoff
(1853-1927) first described visual impairment and par-
esis occurring after physical activity. Because the
patients’ body temperature was not recorded, Uhthoff
assumed that the described symptoms were caused by
the physical activity itself and not by the resulting
increased body temperature. Consequently, MS patients
were advised not to engage in exercise
[14-16,19,46,54,55]. In fact, 60-80% of MS patients
experience a reversible (re)occurrence or aggravation of
neurological symptoms in situations with increased body
temperature, for example during vigorous physical activ-
ity, fever, or a hot bath [14-16,46,54,55]. As a reference
to the first description, the eponym “Uhthoff’s phenom-
enon” has been coined. The underlying cause is thought
to be a temperature dysregulation due to dysautonomia
with subsequent temperature-dependent impairment of
the conduction velocity of partially demyelinated axons
[15,16,54,56]. Not until about 1937, numerous systema-
tic investigations revealed the correlation between
increased body temperature and aggravation of
disability.
Another argument for MS patients to avoid exercise
was the assumption that a “waste” of energy might
aggravate fatigue and reduce ADLs [14] which however
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has never been confirmed. Furthermore, a detrimental
effect of physical activity itself on CNS structures or an
activity-mediated increase of the relapse rate has never
been demonstrated [15,57].
Exercise in MS patients – effects on the immune system
It is well known that exercise may influence susceptibil-
ity to common infectious diseases like upper respiratory
tract infections in different directions [58]. Whereas vig-
orous physical activity such as competitive sport can
lead to an increased susceptibility to infections, moder-
ate exercise may contribute to their prevention
[15,19,57-59].
On the immune cell level, physical strain in healthy
subjects has been demonstrated to initially increase the
peripheral lymphocyte count which subsequently falls to
below the initial level after cessation of the physical
activity [19,60,61]. The resulting lymphocyte reduction
was short-lasting with a maximum duration of 3-24 h
[19,58,60] and was shown to be more prominent in Th1
cells than in Th2 cells [61-63]. As Th1 cells primarily
secrete pro-inflammatory cytokines like IFN-g, IL-2, and
TNF-a whereas Th2 rather secrete anti-inflammatory
cytokines such as IL-4, IL-5 and IL-10, exercise can pro-
mote a shift from a Th1-mediated pro-inflammatory to
a rather anti-inflammatory Th2-mediated cytokine
milieu [58,60] which is of particular interest because an
imbalance of Th1- and Th2-cells is considered relevant
in MS pathogenesis [62].
Since established immunomodulatory drugs such as
IFN-b or glatiramer acetate exert similar effects on the
immune system, drug treatment and physical activity
may complement each other in terms of modulating the
immune system. The only short lasting effects of exer-
cise on the immune cell level argue for regular and fre-
quent training intervals.
The effect of exercise on cytokine production and
response is less clear and often contradictory
[44,60,62,64], which can in part be explained by differ-
ent populations studied, different training protocols
and/or different readout parameters and paradigms. For
example, Heesen et al. found similar resting serum con-
centrations of IFN- g, TNF- a and IL-10 in trained and
untrained MS patients [62], whereas White et al.
reported reduced resting plasma concentrations of IL-4,
IL-10, C-reactive protein (CRP) and IFN- g and a ten-
dency for decreased TNF- a in MS patients upon eight
weeks of PRE. Muscle contractions are thought to sti-
mulate secretion of IL-6 [44,65]. Likewise, contradictory
data have been published on the effect of exercise on
immunoregulatory IL-6 in MS patients [44,64].
Given the neurodegenerative component of MS, the
effect of physical activity, particularly of exercise on
nerve growth factors is of particular importance. In
rodents, exercise has been shown to stimulate the
release of brain-derived neurotrophic factor (BDNF)
[66], insulin-like growth factor 1 (IGF-1) [67-69] and
vascular endothelial growth factor (VEGF) [70], all of
which support cell proliferation, synaptic plasticity, neu-
roprotection, and neurogenesis in both physiological
and neuroinflammatory conditions [67,71-74]. Also in
humans exercise seems to modify the secretion of neu-
roactive proteins [14,67]. In both healthy participants
and MS patients 30 min of moderate ergometry-based
exercise increased the concentrations of BDNF and
nerve growth factor (NGF) [59,75]. Increased hippocam-
pal BDNF concentrations have been measured upon
moderate exercise [67]. Since the hippocampus is cru-
cially involved in learning and memory tasks and modu-
lation of mood, these findings might connect exercise
with slowing of cognitive impairment and stabilization
of affect in MS patients [67]. An increased secretion of
IGF-1 has so far been demonstrated in healthy people
after exercise [76-78]. IGF-1 as an important factor in
development supports cell survival, brain growth and
CNS myelination. During later phases of life IGF-1
might play a role in neuroprotection and synaptic and
cognitive plasticity [67]. Furthermore, exercise increased
the activity of antioxidant enzymes, which might sup-
port the role of exercise in neuroprotection [67].
Exercise in MS patients – effects on morphology and
imaging findings
Repetitive activation of the motor programs strengthens
the cortical engrams and causes neuroplastic and adap-
tive processes like improved motor unit activation and
synchronization of firing rates. In contrast periods of
inactivity are associated with opposite effects [35,49,79].
Although data on the effect of physical activity on
brain structural parameters are sparse, some evidence
indicates that physiotherapy and regular fitness training
counteract the structural degeneration of brain tissue in
patients with relapsing-remitting MS and possibly have
a neuroprotective impact. Both grey and white matter
atrophy occurs already in early stages of relapsing-remit-
ting MS [80]. However, patients with a higher level of
aerobic fitness were shown to have a comparatively lar-
ger local volume of grey matter in the right post-central
gyrus and midline cortical structures including the fron-
tal medial and the anterior cinguli gyrus and the precu-
neus somatosensory cortex than unfit patients.
Furthermore higher fitness levels were associated with
greater recruitment of cortical regions whereas lower fit-
ness levels were associated with enhanced anterior cin-
gulated cortex activity [81]. These data should however
be treated with caution as they based on a small sample
of 24 female MS patients with a wide range in disability
(EDSS 0-6) and disease duration (1-18 years).
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MS patients have been shown to have more brain
areas, often bilaterally, activated when performing motor
and cognitive tasks compared to healthy controls, possi-
bly as an expression of neuroplasticity [82-92]. The
degree of ipsilateral activation appears to correlate with
the disease course and severity [85,88,93] and is consid-
ered to reflect cortical adaptive reorganization processes
[82,85,86]. For example, in MS patients with primary
progressive disease course movement-associated cortical
activation involved “nonmotor” areas like the insula and
several multimodal cortical regions in the temporal, par-
ietal, and occipital lobes in addition to the “classic”
areas of motor planning and execution regions (includ-
ing the supplementary motor area and the cingulate
motor area) [93]. Morgen et al. reported that thumb
movements of untrained MS patients elicited a more
prominent activation of the contralateral dorsal premo-
tor cortex in fMRI than in healthy controls [85] which
in contrast to healthy controls was not attenuated upon
repetitive thumb movements.
In MS patients the corpus callosum is typically
affected. Besides callosal lesions detected by standard
MRI sequences, diffusion tensor imaging sequences
show ultrastructural damage, reflected by a reduced
fractional anisotropy and increased mean diffusivity
[79,94-98]. Interestingly, in a small study comprising 11
MS patients and healthy controls, Ibrahim et al.
described a significant increase of fractional anisotropy
and mean diffusivity in the corpus callosum after a two
months physiotherapy program of 2 h per week, sug-
gesting that physiotherapy may influence the brain
microstructure in MS [79]. In summary, some data sug-
gest, that effects of exercise in MS patients may be
reflected by morphological changes in the CNS which
may be detectable by advanced imaging techniques.
However, existing data are not yet sufficient to unequi-
vocally prove an impact of exercise on brain structure in
MS.
Personalized exercise in MS patients – general and
specific recommendations
At the start of the 1990s the German Federal Health
Monitoring System’s general recommendation of per-
forming a specific health-related training program at
least three times a week was replaced by a more global
perspective, namely the integration of everyday physical
activities. In the situation of MS patients with an often
reduced everyday activity, regular exercise is particularly
important. Apart from improving muscle strength, exer-
cise is intended to improve endurance, muscle tone and
posture stability, the degree of flexibility, endurance and
and should involve both the agonists and antagonists
[15,35]. A physical training program needs to be tailored
to the individual needs and symptoms of a patient.
Factors to be considered include the course and stage of
disease, the degree of disability, age, concomitant dis-
eases and sequelae. Importantly, it has to be ensured
that the patient is not overstrained [14-16].
Compared to healthy people MS patients have a
reduced aerobic capacity [14,26,38], decreased muscle
strength, retarded rate of muscle tension development,
reduced muscle endurance and impaired balance
[14,15,36,99-101]. A relationship between gait speed and
strength parameters has been postulated [102]. Petajan
and White illustrated the level of muscular fitness and
physical activity of MS patients in two “pyramids": pas-
sive range of motion (ROM) forms the basis of the mus-
cular fitness pyramid and can minimize the risk of
contractures when practiced regularly [16]. The next
step in the pyramid comprises active flexibility and
resistance exercise against or without gravity to maintain
muscle integrity, for example to enable the patient car-
rying out essential daily functions. A well-rounded pro-
gram of muscle strengthening exercise represents the
top of the muscular fitness pyramid [16]. ADLs form
the basis of the physical activity pyramid, followed by
built-in inefficiencies, active recreation, and structured
aerobic training programs. Again, design, frequency, and
intensity of training programs have to be tailored to the
individual patient. Weight-supported exercises like ergo-
metry and water exercise are particularly recommended
for patients with motor deficit or balance disturbances
[16].
No specific recommendations for exercise treatment
exist that are universally valid. However, general thera-
peutic recommendations can be defined. Since exercise
programs have not sufficiently been investigated in
more severely disabled patients, these recommendations
are restricted to MS patients with a maximum EDSS
score of 7 [14,15,34,38]. Any new exercise program
should be initialized by a physiotherapist or exercise
physiologist familiar with the disease [14]. A brief his-
tory including impairments in particular within daily
activities should be elicited [16]. Regardless of the type
of exercise, training programs should be uncomplicated
and comprehensible to the patients. If necessary, it
might be advisable to explain training programs in an
illustrated or written form [15]. Patients should be
supervised until they can perform the program ade-
quately and independently [14-16,26]. Exercise programs
should specifically target weaker muscles, and should
preferably encompass multisegmental complex move-
ments [15,35]. The intensity should be increased only
slowly, and not to the point of pain [15]. Special care
should be paid to peripheral nerves; particularly over-
stretching should be avoided [15]. Training sessions are
recommended to start at a low level, include a light
warm-up, progress according to the patients’ clinical
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state and specific problems, and finally reach light to
moderate intensity [14-16,26]. 10-15 min of daily
stretching to maintain and improve flexibility of muscles
and tendons [15] and recovery time between training
sessions of 24-48 h are recommended [15]. Immobilized
patients or those with severe clinical symptoms should
be individually assisted. Some authors advise that cardi-
opulmonary function and VO2-max should be assessed
prior to treatment start since MS patients may have
reduced heart rate responses in graded exercise testing,
possibly as an expression of cardiovascular dysautono-
mia [15,16], although this probably can hardly be imple-
mented in the daily routine. Regarding endurance
training and according to the American College of
Sports Medicine, White and Dressendorfer recommend
using the actual heart rate response to graded exercise
testing for finding the ideal target heart range for train-
ing [15]. No symptoms should appear and “moderate
intensities” ought to be strived, for example by means of
the Borg scale of perceived exertion, which ranges from
6 to 20 (6 means “no exertion at all”, 20 means “maxi-
mal exertion”). For moderate intensities ranges from 11
to 14 are aspired [15,103]. Depending on the symptoms
and the training program, exercises should be performed
at home, individually, with a training partner, or with a
training group, and may include training equipment
such as elastic bands, additional weights and pulley sys-
tems. Due to its social support a training group seems
to be favorable in terms compliance and motivation
[16,28]. To achieve similar effects in home-based train-
ing programs, patients should be closely supervised, for
example by visits or telephone calls [16,28]. Most
importantly, the training sessions have to be performed
regularly [14-16,26].
Some special recommendations regarding exercise
training for MS patients have been published. However,
it has to be emphasized that these recommendations
mostly represent personal experiences made by the
authors and are not always supported by high standard
clinical trials. Dalgas et al., for example, recommended
endurance training of approximately 10-40 min dura-
tion, with an initial training intensity of 50-70% of VO2-
max corresponding to 60-80% of maximum heart rate
[14]. According to Dalgas et al., resistance training is
recommended to initially comprise 8-15 repetitions
which can then be increased over several months. The
training should start with 1-3 sets, later 3-4 sets with a
2-4 min break between sets and should be performed
two or three times per week. For heat-sensitive patients
and those who regularly develop Uhthoff’s phenomenon
exercise training in the morning or in water at tempera-
tures of 27-28°C could be preferable since body tem-
perature is physiologically lower early in the day and
heat generated by physical activity is quickly dissipated
in water [15,16]. Alternatively, cooling before exercise
and/or during physical activity for example by cold
packs may help to prevent Uhthoff’s phenomenon
[15,16,55]. Also, resistance instead of endurance training
could be preferable for heat-sensitive patients [14].
Physical therapy approaches to prevent or
alleviate individual target symptoms and signs in
MS
Fatigue
Fatigue, defined as an extreme physical and mental
tiredness inadequate to the preceding demand, is a fre-
quent, often very debilitating symptom in MS, which is
generally difficult to treat [8-10,15,35,104-106]. Approxi-
mately 75-90% of all MS patients experience fatigue dur-
ing disease progression [8,10,16] and some MS patients
end up in a vicious circle: out of a wish to reduce fati-
gue they decrease physical activity which over time
reduces endurance, muscle strength, and quality of life
and may enhance fatigue, which then thus in turn
further limits physical activity and social life [9,42,49].
Apart from cooling, moderate exercise, particularly aero-
bic training, seems to have a positive effect on fatigue
[30,35,45]. Because fatigue often increases over the day,
training sessions should be performed in the morning
and must not overexert the patient [104]. Special sup-
ports like participation in a training group or attending
psychological support to increase motivation for conti-
nuation of training over time could be advantageous in
patients suffering from fatigue [16]. Energy saving strate-
gies are also applied, in which the patient learns to
prior-itize and to perform everyday tasks with a mini-
mum of exertion [4,16,27]. Although a beneficial effect
of moderate exercise on fatigue has been described by
some authors [14,28,35,41], effects are usually insuffi-
cient to achieve significant improvements in current
fatigue scales [17,35,45,47,50]. Other studies completely
failed to detect any improvements [33]. One explanation
for contradicting results can be found in the use of dif-
ferent fatigue scales, which focus on physical symptoms,
or in attendant sleep disturbances such as insomnia,
sleep related breathing disorders, restless legs syndrome,
periodic limb movement disorder [104-106]. In conclu-
sion, there is some however not unequivocal evidence
for low to moderate beneficial effects of moderate exer-
cise on fatigue.
Spasticity
With a lifetime prevalence of about 90% spasticity is fre-
quent in MS and has a potential to significantly reduce
quality of life [104]. It leads to limitations in the range
and normal pursuit of movements, results in malposi-
tioning of the joints, and is often accompanied by pain
[24]. Controlled studies on exercise and physiotherapy
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for MS-related spasticity are rare; however some evi-
dence for improvements has been reported [104].
Physical therapy measures include active and passive
exercise (e.g. targeted positioning of the patient, passive
exercise using motorized cycles, active treadmill exer-
cise) which can be assisted by a training partner or
training equipment such as elastic bands. Physiothera-
peutic techniques according to Bobath or Vojta and pro-
prioceptive neuromuscular facilitation (PNF) are among
the treatments applied. None of these measures has
been proven to be superior [104,107]. It is most impor-
tant to carry them out regularly and with a sufficient
intensity [4,104]. Light stretching of the affected muscle
groups with duration of approximately 20-60 s should
be performed prior to and after exercise [15].
Pareses
Pareses lead to various physical disabilities, such as diffi-
culty in walking and fine-motor dysfunction. A relation-
ship between gait speed and muscle strength in MS
patients has been shown [14]. As no drug treatment for
pareses exists and antispastic drugs such as baclofen
may also lead to a worsening of existing pareses, physi-
cal and occupational therapy techniques are the sole
treatment option. Because of reduced impact of gravity
aquatic training allows patients with even severe pareses
of the lower extremities to perform standing and mov-
ing exercises [15,16]. A standing frame can help patients
who are unable to stand, to train torso, limb, and
respiratory muscles and protects against cardiovascular
dysregulation. For immobilized patients, passive range of
motion exercises proximal to the paralyzed region is
recommended [15,16]. Various studies have shown a sig-
nificant improvement of muscle strength due to exercise
[33,35,40,101]. Furthermore some authors reported ben-
eficial effects in walking speed, stepping endurance, stair
climbing, and timed up and go test [35,40,49]. In sum-
mary, evidence suggests that exercise is beneficial in the
treatment of MS-related pareses, however again, only
few, partially inconsistent data are available. Moreover,
effects of exercise have been studied almost exclusively
in MS patients with mild or moderate impairment.
Coordination and balance dysfunction
Abnormalities in balance control are frequent symptoms
in MS patients, which restrict patients in their daily liv-
ing activities and increase risk of falls [5]. Balance skills
like standing and walking, as well as the patients’ per-
ception of their own balance are important to assess [5].
The sitting position of cycling training is advantageous
for unsteady patients [15,16]. Only a few studies investi-
gated the influence of exercise programs on balance and
coordination in MS and very few have chosen these
variables as primary outcome parameter. Catteneo et al.,
for example, investigated the effect of balance training
in 44 MS patients in a randomized controlled trial [5].
Two treatment groups received particular balance reha-
bilitation for three weeks, a third (control) group partici-
pated an unspecific training program. In both treatment
groups a reduction of the number of falls and an
improvement in clinical tests of static balance (Berg Bal-
ance Scale) and dynamic balance (Dynamic Gait Index)
could be detected. However, in self-assessment scales
patients did not report significant improvements [5].
Another controlled study did not support a beneficial
effect of exercise training on static balance [34].
Cognitive and mood disturbances
Depending on the disease course and stage 45-70% of
MS patients are affected by cognitive impairments like
reduced information processing speed, attentional defi-
cits and episodic memory deficits [12,13,24,104,108] and
60-70% experience mood disturbances [13,109,110].
Some evidence for a positive correlation between aero-
bic exercise and cognition and brain function in healthy
people has been described [81]. In MS patients, benefi-
cial effects of regular physical activity and exercise on
mood [18,32,35,48] and quality of life [14,15,28,34] have
been repeatedly reported. Valid data on the effect on
cognitive function are hardly available.
Conclusion and outlook
Several lines of evidence suggest that MS patients bene-
fit from regular physical activity and exercise with
respect to clinical, imaging and physiological parameters.
However, the quality of so far realized clinical trials on
exercise training in MS do not always satisfy the
requirements of a high standard study. Moreover,
because of different treatment paradigms and endpoints,
data are often hardly comparable. Thus, many questions
remain still unanswered. In consequence, there is a
great need for standardized high quality and well
described studies that address both short and long term
effects of exercise on clinical and paraclinical parameters
in MS patients with different disease courses and differ-
ent grades of disability.
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